Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by bayoubuckson Jul 17, 2014 5:56pm

294 Views

Post# 22757230

Roger's timelines

Do you trust Roger's timelines? Go to the Aug 29, 2013 MD&A and see what he said about the TLC-2000. He said they were on track to launch 20 commercial prototypes for Beta testing purposes in 1Q, 2014 and then commercially launch the TLC-2000 in 1Q. Now he says it will be 4Q.
This is why I'm very sceptical about his timeline forecasting.
I'll probably be accused of being a basher by those with their head in the sand (or elsewhere), but the facts speak for themselves.

Bullboard Posts

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal